Lysine Methyltransferase SMYD1 Regulates Myogenesis via skNAC Methylation
Cells · 22.06.2023 · 12 (13) · 1695
DOI: 10.3390/cells12131695 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 22.06.2023. Verfasst von Li Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biosciences, The University of Texas at Austin, 1 University Station A5000, Austin, TX 78712, USA. Hauptthemen laut MEDLINE: DNA-Binding Proteins, Gene Expression Regulation, Developmental, Histone-Lysine N-Methyltransferase, Molecular Chaperones. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NIAAA NIH HHS.
Abstract (Originalsprache)
The SMYD family is a unique class of lysine methyltransferases (KMTases) whose catalytic SET domain is split by a MYND domain. Among these, Smyd1 was identified as a heart- and skeletal muscle-specific KMTase and is essential for cardiogenesis and skeletal muscle development. SMYD1 has been characterized as a histone methyltransferase (HMTase). Here we demonstrated that SMYD1 methylates Skeletal muscle-specific splice variant of the Nascent polypeptide-Associated Complex (skNAC) transcription factor. SMYD1-mediated methylation of skNAC targets K1975 within the carboxy-terminus region of skNAC. Catalysis requires physical interaction of SMYD1 and skNAC via the conserved MYND domain of SMYD1 and the PXLXP motif of skNAC. Our data indicated that skNAC methylation is required for the direct transcriptional activation of myoglobin (Mb), a heart- and skeletal muscle-specific hemoprotein that facilitates oxygen transport. Our study revealed skNAC as a methylation target of SMYD1, illuminates the molecular mechanism by which SMYD1 cooperates with skNAC to regulate transcriptional activation of genes crucial for muscle functions and implicates the MYND domain of the SMYD-family KMTases as an adaptor to target substrates for methylation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biosciences, The University of Texas at Austin, 1 University Station A5000, Austin, TX 78712, USA.
- Department of Pathology, Lokey Stem Cell Research Building, 1291 Welch Rd Rm. G2035, Stanford, CA 94305, USA.
- Department of Clinical Sciences and Cell and Molecular Biology, Colorado State University, Fort Collins, CO 80523, USA.
- Flare Therapeutics, Cambridge, MA 02142, USA.
- Center for Biomedical Research Services, Department of Neuroscience, The University of Texas at Austin, 2500 Speedway A4800, Austin, TX 78712, USA.
- Thoracic/Head and Neck Medical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA.
ORCID-Profile: Haley O Tucker
Förderung
- NIH HHS
- NCI NIH HHS
- NIAAA NIH HHS
- NIH
- Cancer Prevention Research Institute of Texas (CPRIT)
- Marie Betzner Morrow Centennial Endowment
Zitieren
APA
Zhu, L., Brown, M. A., Sims, R. J., Tiwari, G. R., Nie, H., Mayfield, R. D., & Tucker, H. O. (2023). Lysine Methyltransferase SMYD1 Regulates Myogenesis via skNAC Methylation. Cells, 12(13), 1695. https://doi.org/10.3390/cells12131695
Vancouver
Zhu L, Brown MA, Sims RJ, Tiwari GR, Nie H, Mayfield RD, et al. Lysine Methyltransferase SMYD1 Regulates Myogenesis via skNAC Methylation. Cells. 2023;12(13):1695. doi:10.3390/cells12131695
BibTeX
@article{Zhu2023,
author = {Zhu, Li and Brown, Mark A and Sims, Robert J and Tiwari, Gayatri R and Nie, Hui and Mayfield, R Dayne and Tucker, Haley O},
title = {Lysine Methyltransferase SMYD1 Regulates Myogenesis via skNAC Methylation},
journal = {Cells},
year = {2023},
volume = {12},
number = {13},
pages = {1695},
doi = {10.3390/cells12131695}
}
EUVIMED